PharmaBlock Sciences (Stock Code: 300725.SZ) today announced the commissioning of its first peptide pilot-scale GMP plant at ...

SAN FRANCISCO, Feb. 18, 2026 /PRNewswire/ -- CyanoCapture, the innovator in cyanobacteriabased oral drug delivery, and Persist AI, the leader in AI-driven robotic pharmaceutical formulation, today ...

STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic ...

In this free webinar, gain insight into how modular process and facility design enable flexible, scalable peptide manufacturing, allowing standardized production modules to be configured and ...

Drug development and production rely on stringent quality controls, reproducibility, and verification. Biopharmaceuticals, including protein-based therapies, require extensive characterization, ...

The Peptide-Builder is designed for peptide chemists who want to make high-quality peptides quickly and easily at a laboratory scale. Peptides are synthesized sequentially and fully automated either ...

An analysis of launched peptide drugs and compounds in late-stage development indicated that the peptide market would grow in 2006 at a rate of approximately 5%. Beginning in late 2007, Phase III and ...

Scientists have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable ...

Peptide injections are the hottest trend in wellness. Researchers say enthusiasm for these unregulated drugs has got ahead of ...

NANJING, China, June 4, 2026 /PRNewswire/ -- PharmaBlock Sciences (Stock Code: 300725.SZ) today announced the commissioning of its first peptide pilot-scale GMP plant at PharmaBlock Zhejiang ...